Hypopituitarism differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(66 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Hypopituitarism}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Hypopituitarism]]
{{CMG}}; {{AE}}
{{CMG}}; {{AE}} {{IQ}}, {{AEL}}  


{{PleaseHelp}}
==Overview==
Hypopituitarism should be differentiated from other diseases causing [[panhypopituitarism]], [[hypothyroidism]], [[hypogonadism]], [[Adrenocorticotropic hormone|ACTH deficiency]], [[Growth hormone|GH]] deficiency, [[Antidiuretic hormone|ADH]] deficiency and high [[prolactin]] level.
 
==Differentiating Hypopituitarism From Other Diseases==
*For the differential of hypopituitarism on the basis of [[thyroid hormone]] deficiency, [[Hypopituitarism differential diagnosis#Differentiating hypopituitarism from hypothyroidism that present as a single hormonal deficiency|click here.]]
*For the differential of hypopituitarism on the basis of [[panhypopituitarism]], [[Hypopituitarism differential diagnosis#Differentiating various causes of Panhypopituitarism|click here.]]
*For the differential of hypopituitarism on the basis of [[gonadotropins]] ([[FSH]]/[[Luteinizing hormone|LH]]) deficiency, [[Hypopituitarism differential diagnosis#Differentiating hypopituitarism on the basis of Gonadotropins (FSH/LH) deficiency|click here.]]
*For the differential of hypopituitarism on the basis of high [[prolactin]] level, [[Hypopituitarism differential diagnosis#Differentiating hypopituitarism on the basis of High prolactin level|click here.]]
*For the differential of hypopituitarism on the basis of [[growth hormone]] deficiency, [[Hypopituitarism differential diagnosis#Differentiating hypopituitarism on the basis of GH Deficiency|click here.]]
*For the differential of hypopituitarism on the basis of [[Antidiuretic hormone|ADH]] deficiency, [[Hypopituitarism differential diagnosis#Differentiating hypopituitarism on the basis of ADH deficiency|click here.]]
 
===Differentiating various causes of Panhypopituitarism===
Hypopituitarism should be differentiated from other diseases causing [[panhypopituitarism]], [[hypothyroidism]], [[hypogonadism]], [[Adrenocorticotropic hormone|ACTH deficiency]], [[Growth hormone|GH]] deficiency, [[Antidiuretic hormone|ADH]] deficiency and high [[prolactin]] level.<ref name="pmid9541295">{{cite journal |vauthors=Sato N, Sze G, Endo K |title=Hypophysitis: endocrinologic and dynamic MR findings |journal=AJNR Am J Neuroradiol |volume=19 |issue=3 |pages=439–44 |year=1998 |pmid=9541295 |doi= |url=}}</ref><ref name="pmid7758238">{{cite journal |vauthors=Powrie JK, Powell M, Ayers AB, Lowy C, Sönksen PH |title=Lymphocytic adenohypophysitis: magnetic resonance imaging features of two new cases and a review of the literature |journal=Clin. Endocrinol. (Oxf) |volume=42 |issue=3 |pages=315–22 |year=1995 |pmid=7758238 |doi= |url=}}</ref><ref name="pmid26262437">{{cite journal |vauthors=Honegger J, Schlaffer S, Menzel C, Droste M, Werner S, Elbelt U, Strasburger C, Störmann S, Küppers A, Streetz-van der Werf C, Deutschbein T, Stieg M, Rotermund R, Milian M, Petersenn S |title=Diagnosis of Primary Hypophysitis in Germany |journal=J. Clin. Endocrinol. Metab. |volume=100 |issue=10 |pages=3841–9 |year=2015 |pmid=26262437 |doi=10.1210/jc.2015-2152 |url=}}</ref><ref name="pmid7629223">{{cite journal |vauthors=Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E, Ezzat S |title=Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings |journal=J. Clin. Endocrinol. Metab. |volume=80 |issue=8 |pages=2302–11 |year=1995 |pmid=7629223 |doi=10.1210/jcem.80.8.7629223 |url=}}</ref><ref name="pmid8345854">{{cite journal |vauthors=Imura H, Nakao K, Shimatsu A, Ogawa Y, Sando T, Fujisawa I, Yamabe H |title=Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus |journal=N. Engl. J. Med. |volume=329 |issue=10 |pages=683–9 |year=1993 |pmid=8345854 |doi=10.1056/NEJM199309023291002 |url=}}</ref><ref name="pmid21668725">{{cite journal |vauthors=Hsieh CY, Liu BY, Yang YN, Yin WH, Young MS |title=Massive pericardial effusion with diastolic right ventricular compression secondary to hypothyroidism in a 73-year-old woman |journal=Emerg Med Australas |volume=23 |issue=3 |pages=372–5 |year=2011 |pmid=21668725 |doi=10.1111/j.1742-6723.2011.01425.x |url=}}</ref><ref name="pmid9747750">{{cite journal |vauthors=Dejager S, Gerber S, Foubert L, Turpin G |title=Sheehan's syndrome: differential diagnosis in the acute phase |journal=J. Intern. Med. |volume=244 |issue=3 |pages=261–6 |year=1998 |pmid=9747750 |doi= |url=}}</ref>
 
{| class="wikitable"
! rowspan="3" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Diseases}}
! rowspan="3" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Onset}}
! colspan="5" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Manifestations}}
! colspan="4" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Diagnosis}}
|-
! colspan="4" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|History and Symptoms}}
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Physical examination}}
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Laboratory findings}}
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Gold standard}}
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF| Imaging}}
! rowspan="2" style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Other investigation findings}}
|-
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF| Trumatic delivery}}
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF| Lactation failure}}
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF| Menstrual irregularities}}
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF| Other features}}
|-
![[Panhypopituitarism]]
|Chronic
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|[[Oligomenorrhea|Oligo]]/[[amenorrhea]]
|
* [[Polyuria]]
 
* [[Polydipsia]]
* Features of [[hypothyroidism]] and [[hypoadrenalism]]
|
* [[Growth failure]]
 
* B/L [[hemianopsia]]
 
* [[Papilledema]]
|
* All pituitary hormones decreased
|
* [[Magnetic resonance imaging|MRI]]
|
|
* Left hand and wrist [[radiograph]] for [[bone age]]
|-
![[Sheehan's syndrome]]
|Acute
|<nowiki>++</nowiki>
| ++
|[[Oligomenorrhea|Oligo]]/[[amenorrhea]]
|
* [[Adrenal insufficiency]] symptoms
 
* [[Hypothyroidism]] features
|
* [[Breast tissue]] [[atrophy]]
 
* Decreased [[axillary]] and [[pubic]] hair growth
|
* [[Pancytopenia]]
 
* [[Eosinophilia]]
 
* [[Hyponatremia]]
 
* Low [[fasting plasma glucose]]
 
* Decreased levels of [[anterior pituitary]] [[hormones]] in blood
 
|
* Dx is clinical 
 
* Most sensitive test: low baseline [[prolactin]] levels w/o response to [[Thyrotropin-releasing hormone|TRH]]
|CT/MRI:
* Sequential changes of pituitary enlargement followed by
* Shrinkage and [[necrosis]] leading to decreased sellar volume or [[empty sella]]
|
* Pituitary hormone stimulation tests ([[Metoclopramide]] and [[clomiphene citrate]] stimulation tests)
|-
![[Lymphocytic hypophysitis]]
|Acute
|<nowiki>+/-</nowiki>
|<nowiki>+</nowiki>
|[[Oligomenorrhea|Oligo]]/[[amenorrhea]]
|
* Associated with [[autoimmune]] conditions
 
* Generalized [[headache]]
 
* Retro-orbital or Bitemporal [[pain]]
 
* Mass lesion effect such as [[Visual field defect|visual field defects]]
|
* [[Diabetes insipidus|DI]]
 
* [[Autoimmune]] [[thyroiditis]]
|
* Decreased pituitary hormones([[Gonadotropins]] most common)
 
* [[Hyperprolactinemia]](40%)
 
* [[Growth hormone|GH]] excess
|
* [[Pituitary gland|Pituitary]] [[biopsy]]: [[lymphocytic]] [[Infiltration (medical)|infiltration]]
|
* [[CT]] & [[MRI]]: Features of a [[Pituitary gland|pituitary]] [[mass]]
 
* Diffuse and homogeneous contrast enhancement
|[[Assay|Assays]] for:
* Anti-TPO 
* Anti-Tg Ab
|-
![[Pituitary apoplexy]]
|Acute
|<nowiki>+/-</nowiki>
|<nowiki>++</nowiki>
|[[Oligomenorrhea|Oligo]]/[[amenorrhea]]
|Severe [[headache]]
* [[Nausea and vomiting]]
* Paralysis of eye muscles ([[diplopia]])
* Changes in vision
|
* [[Visual acuity]] defects
 
* [[Cranial nerve palsies|CN palsies]] (nerves III, IV, V , and VI)
 
|
* Decreased levels of [[anterior]] pituitary hormones in blood.
|
* [[Magnetic resonance imaging|MRI]]
|
* [[CT]] scan without [[Contrast medium|contrast]]: Hemorrhag<nowiki/>e on [[CT]] presents as a hyperdense lesion
 
* [[MRI]]: If inconclusive [[CT]]
|
[[Blood tests]] may be done to check:
* [[PT]]/[[INR]] and [[aPTT]]
 
* [[Pituitary gland|Pituitary]] [[hormonal]] assay
|-
![[Empty sella syndrome]]
|Chronic
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|[[Oligomenorrhea|Oligo]]/[[amenorrhea]]
|
* [[Erectile dysfunction]]
 
* [[Headache]]
 
* Low [[libido]]
 
|
* Signs of raised [[intracranial pressure]] may be present
 
* [[Nipple discharge|Nipple]] discharge
|
* Decreased levels of  pituitary hormones in blood.
|
* [[MRI]]
|
* [[Empty sella]] containing [[Cerebrospinal fluid|CSF]]
|
* Pituitary hormone stimulation tests ([[Metoclopramide]] and [[clomiphene citrate]] stimulation tests)
|-
![[Simmond's Disease|Simmond's disease]]/[[Pituitary]] [[cachexia]]
|Chronic
|<nowiki>+/-</nowiki>
| +
|[[Oligomenorrhea|Oligo]]/[[amenorrhea]]
|
* [[Cachexia]]
* [[Premature aging|Premature]] aging
|
* Progressive [[emaciation]]
 
* Loss of body hair
|
* Decreased levels of anterior pituitary hormones in blood.
|
* [[Magnetic resonance imaging|MRI]]
|
|
* Pituitary hormone stimulation tests ([[Metoclopramide]] and [[clomiphene citrate]] stimulation tests)
|}
===Differentiating hypopituitarism from hypothyroidism that present as a single hormonal deficiency===
<ref name="pmid1578958">{{cite journal |vauthors=Colon-Otero G, Menke D, Hook CC |title=A practical approach to the differential diagnosis and evaluation of the adult patient with macrocytic anemia |journal=Med. Clin. North Am. |volume=76 |issue=3 |pages=581–97 |year=1992 |pmid=1578958 |doi= |url=}}</ref> <ref name="pmid15643019">{{cite journal |vauthors=Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT |title=Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society |journal=J. Clin. Endocrinol. Metab. |volume=90 |issue=1 |pages=581–5; discussion 586–7 |year=2005 |pmid=15643019 |doi=10.1210/jc.2004-1231 |url=}}</ref><ref name="pmid25347444">{{cite journal |vauthors=Rugge JB, Bougatsos C, Chou R |title=Screening and treatment of thyroid dysfunction: an evidence review for the U.S. Preventive Services Task Force |journal=Ann. Intern. Med. |volume=162 |issue=1 |pages=35–45 |year=2015 |pmid=25347444 |doi=10.7326/M14-1456 |url=}}</ref><ref name="pmid22954017">{{cite journal |vauthors=Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA |title=Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association |journal=Thyroid |volume=22 |issue=12 |pages=1200–35 |year=2012 |pmid=22954017 |doi=10.1089/thy.2012.0205 |url=}}</ref>
{| class="wikitable" align="center" style="border: 0px; margin: 3px;"
! colspan="2" rowspan="2" align="center" style="background: #4479BA; color: #FFFFFF; " |Disease
! colspan="3" align="center" style="background: #4479BA; color: #FFFFFF; " |History and symptoms
! colspan="7" align="center" style="background: #4479BA; color: #FFFFFF; " |Laboratory findings
! rowspan="2" align="center" style="background: #4479BA; color: #FFFFFF; " |Additional findings
|-
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Fever
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Goiter
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Pain
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Free T4
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3RU
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Thyroglobin
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TRH
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TPOAb
|-
| rowspan="3" style="background:#DCDCDC;" |Primary hypothyroidism
| align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis|Autoimmune]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/-
Diffuse
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''''↓'''''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''''↓'''''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* May be accompanied by other [[autoimmune diseases]]
|-
| align="center" style="background:#DCDCDC;" |[[Thyroiditis]]
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''''↓'''''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
*[[Thyroiditis|Infectious thyroiditis]] associated with [[neck pain]]
|-
| align="center" style="background:#DCDCDC;" |Others
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''''↓'''''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* History of [[hyperthyroidism]]
* Drug history
|-
| colspan="2" style="background:#DCDCDC;" |Transient hypothyroidism
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +/-
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* May present primarily with [[hyperthyroidism]]
|-
| colspan="2" style="background:#DCDCDC;" |Subclinical hypothyroidism
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑'''
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Asymptomatic
|-
| rowspan="2" align="center" style="background:#DCDCDC;" |Central Hypothyroidism
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |Pituitary
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| rowspan="2" align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''''↓'''''
| rowspan="2" align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''''↓'''''
| rowspan="2" align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''''↓'''''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↓'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Other [[Pituitary hormone|pituitary hormone deficiencies]] signs
|-
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |Hypothalamus
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | +
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↓'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |↓
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Other [[Pituitary hormone|pituitary hormone deficiencies]] signs
|-
| colspan="2" style="background:#DCDCDC;" |Resistance to TSH/TRH
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | -
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''''↓'''''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''''↓'''''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑'''/'''''↓'''''
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal
| align="left" style="padding: 5px 5px; background: #F5F5F5;" |
* Rare
|}
''Legend:'<nowiki/>'''TSH: Thyroid stimulating hormone, T4: Teraiodothyronine, T3: Triiodothyronine, T3RU: Triiodothyronine reuptake, TRH: Thyrotrophin releasing hormone, TPOAb: Thyroid peroxidase antibody, N: Normal, +: Present, -: Absent'''''
 
===Differentiating hypopituitarism on the basis of Gonadotropins (FSH/LH) deficiency===
 
<ref name="fertstert2004">{{Citation|last = Denschlag|first = Dominik, MD|last2 = Clemens|first2 = Tempfer, MD|last3 = Kunze|first3 = Myriam, MD|last4 = Wolff|first4 = Gerhard, MD|last5 = Keck|first5 = Christoph, MD|title = Assisted reproductive techniques in patients with Klinefelter syndrome: A critical review|journal = Fertility and Sterility|volume = 82|issue = 4|pages = 775–779|date = October 2004|year = 2004|doi = 10.1016/j.fertnstert.2003.09.085}}</ref><ref name="pmid17462053">{{cite journal| author=Virtanen HE, Bjerknes R, Cortes D, Jørgensen N, Rajpert-De Meyts E, Thorsson AV et al.| title=Cryptorchidism: classification, prevalence and long-term consequences. | journal=Acta Paediatr | year= 2007 | volume= 96 | issue= 5 | pages= 611-6 | pmid=17462053 | doi=10.1111/j.1651-2227.2007.00241.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17462053  }}</ref><ref name="pmid19679025">{{cite journal| author=Schmitz D, Safranek S| title=Clinical inquiries. How useful is a physical exam in diagnosing testicular torsion? | journal=J Fam Pract | year= 2009 | volume= 58 | issue= 8 | pages= 433-4 | pmid=19679025 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19679025  }}</ref><ref name="pmid19378875">{{cite journal |vauthors=Trojian TH, Lishnak TS, Heiman D |title=Epididymitis and orchitis: an overview |journal=Am Fam Physician |volume=79 |issue=7 |pages=583–7 |year=2009 |pmid=19378875 |doi= |url=}}</ref><ref name="pmid21490048">{{cite journal |vauthors=Stewart A, Ubee SS, Davies H |title=Epididymo-orchitis |journal=BMJ |volume=342 |issue= |pages=d1543 |year=2011 |pmid=21490048 |doi= |url=}}</ref><ref name="AMN">{{cite web | author = Christine Cortet-Rudelli, Didier Dewailly | title =Diagnosis of Hyperandrogenism in Female Adolescents| work =Hyperandrogenism in Adolescent Girls | url=http://www.health.am/gyneco/more/diagnosis-of-hyperandrogenism-in-female/ | year = 2006 | month= Sep 21 | publisher=Armenian Health Network, Health.am}}</ref><ref>{{cite journal |author=Legro RS, Barnhart HX, Schlaff WD |title=Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome|journal=N Engl J Med|volume=356 |issue=6 |pages=551-566 |year=2007 |pmid=17287476 |doi=}}</ref><ref name="pmid25992748">{{cite journal |vauthors=Brunham RC, Gottlieb SL, Paavonen J |title=Pelvic inflammatory disease |journal=N. Engl. J. Med. |volume=372 |issue=21 |pages=2039–48 |year=2015 |pmid=25992748 |doi=10.1056/NEJMra1411426 |url=}}</ref><ref name="pmid27107781">{{cite journal |vauthors=Ford GW, Decker CF |title=Pelvic inflammatory disease |journal=Dis Mon |volume=62 |issue=8 |pages=301–5 |year=2016 |pmid=27107781 |doi=10.1016/j.disamonth.2016.03.015 |url=}}</ref><ref name="pmid11949938">{{cite journal| author=Murphy AA| title=Clinical aspects of endometriosis. | journal=Ann N Y Acad Sci | year= 2002 | volume= 955 | issue=  | pages= 1-10; discussion 34-6, 396-406 | pmid=11949938 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11949938  }}</ref>
{| class="wikitable"
! colspan="2" align="center" style="background: #4479BA; color: #FFFFFF; " |Diseases
! align="center" style="background: #4479BA; color: #FFFFFF; " |Clinical findings
! align="center" style="background: #4479BA; color: #FFFFFF; " |Diagnosis
! align="center" style="background: #4479BA; color: #FFFFFF; " |Manangement
|-
| rowspan="3" |Congenital diseases
|[[Klinefelter syndrome]]
|Clinical features of [[Klinefelter syndrome]] are as the following:<ref name="fertstert2004">{{Citation|last = Denschlag|first = Dominik, MD|last2 = Clemens|first2 = Tempfer, MD|last3 = Kunze|first3 = Myriam, MD|last4 = Wolff|first4 = Gerhard, MD|last5 = Keck|first5 = Christoph, MD|title = Assisted reproductive techniques in patients with Klinefelter syndrome: A critical review|journal = Fertility and Sterility|volume = 82|issue = 4|pages = 775–779|date = October 2004|year = 2004|doi = 10.1016/j.fertnstert.2003.09.085}}</ref>
* Language learning impairment.
 
* [[Neuropsychological]] testing often reveals deficits in [[executive functions]].
* Delays in motor development.
|
* [[Karyotype|Karyotyping]]
* [[Semen]] count
* [[Serum]] [[estradiol]] levels (a type of [[estrogen]])
* [[Serum]] [[follicle stimulating hormone]]
* [[Serum]] [[luteinizing hormone]]
* [[Serum]] [[testosterone]]
|
* [[Testosterone]] [[therapy]] may be indicated to treat the symptoms of the disease
|-
|[[Kallmann syndrome]]
|Clinical features of Kallmann syndrome include:
* Hypogonadism
* [[Anosmia]]
|
* [[Serum]] [[follicle stimulating hormone]]
* [[Serum]] [[luteinizing hormone]]
* [[Serum]] [[testosterone]]
* [[Gonadotropins|Gonadotropin hormones]]
|
* [[Testosterone|Testosterone replacement therapy]]
* [[Estrogen]] replacement therapy (in females)
|}
 
=== Differentiating hypopituitarism on the basis of High prolactin level ===
<ref name="pmid910825">{{cite journal| author=Rigg LA, Lein A, Yen SS| title=Pattern of increase in circulating prolactin levels during human gestation. | journal=Am J Obstet Gynecol | year= 1977 | volume= 129 | issue= 4 | pages= 454-6 | pmid=910825 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=910825  }} </ref><ref name="pmid15316045">{{cite journal| author=Levy A| title=Pituitary disease: presentation, diagnosis, and management. | journal=J Neurol Neurosurg Psychiatry | year= 2004 | volume= 75 Suppl 3 | issue=  | pages= iii47-52 | pmid=15316045 | doi=10.1136/jnnp.2004.045740 | pmc=1765669 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15316045  }} </ref><ref name="pmid4199418">{{cite journal| author=Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH| title=Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. | journal=J Clin Invest | year= 1973 | volume= 52 | issue= 9 | pages= 2324-9 | pmid=4199418 | doi=10.1172/JCI107421 | pmc=333037 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4199418  }} </ref><ref name="pmid26958514">{{cite journal| author=Jha SK, Kannan S| title=Serum prolactin in patients with liver disease in comparison with healthy adults: A preliminary cross-sectional study. | journal=Int J Appl Basic Med Res | year= 2016 | volume= 6 | issue= 1 | pages= 8-10 | pmid=26958514 | doi=10.4103/2229-516X.173984 | pmc=4765284 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26958514  }} </ref><ref name="Ben-Menachem2006">{{cite journal|last1=Ben-Menachem|first1=Elinor|title=Is Prolactin a Clinically Useful Measure of Epilepsy?|journal=Epilepsy Currents|volume=6|issue=3|year=2006|pages=78–79|issn=1535-7597|doi=10.1111/j.1535-7511.2006.00104.x}}</ref><ref name="pmid737437">{{cite journal| author=Trimble MR| title=Serum prolactin in epilepsy and hysteria. | journal=Br Med J | year= 1978 | volume= 2 | issue= 6153 | pages= 1682 | pmid=737437 | doi= | pmc=1608938 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=737437  }} </ref><ref name="pmid11048906">{{cite journal| author=David SR, Taylor CC, Kinon BJ, Breier A| title=The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. | journal=Clin Ther | year= 2000 | volume= 22 | issue= 9 | pages= 1085-96 | pmid=11048906 | doi=10.1016/S0149-2918(00)80086-7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11048906  }} </ref><ref name="pmid777023">{{cite journal| author=McCallum RW, Sowers JR, Hershman JM, Sturdevant RA| title=Metoclopramide stimulates prolactin secretion in man. | journal=J Clin Endocrinol Metab | year= 1976 | volume= 42 | issue= 6 | pages= 1148-52 | pmid=777023 | doi=10.1210/jcem-42-6-1148 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=777023  }} </ref><ref name="pmid1268617">{{cite journal| author=Steiner J, Cassar J, Mashiter K, Dawes I, Fraser TR, Breckenridge A| title=Effects of methyldopa on prolactin and growth hormone. | journal=Br Med J | year= 1976 | volume= 1 | issue= 6019 | pages= 1186-8 | pmid=1268617 | doi= | pmc=1639736 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1268617  }} </ref>
{| class="wikitable"
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical Findings
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Laboratory findings
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Management
|-
|[[Somatotroph adenoma]]:
[[Acromegaly]]
|Clinical features of [[acromegaly]] are due to high level of [[Growth hormone|human growth hormone]] ([[Growth hormone|hGH]]):
* [[Soft tissue]] [[swelling]] of the hands and feet
 
* Brow and lower jaw protrusion
* Enlarged hands
* Enlarged feet
* [[Arthritis]] and [[carpal tunnel syndrome]]
* Increase in teeth spacing
* [[Macroglossia]] (enlarged tongue)
* [[Heart failure]]
* [[Kidney failure]]
* Compression of the [[optic chiasm]] leading to loss of [[vision]] in the outer [[visual fields]] (typically [[bitemporal hemianopia]])
* [[Headache]]
* [[Diabetes mellitus]]
* [[Hypertension]]
* [[Cardiomegaly]]
|
* Elevated [[insulin-like growth factor-1]] ([[Insulin-like growth factor-I|IGF-1]]) levels
* Elevated [[growth hormone]] levels
|
* Medical management:
** [[Octreotide]]
** [[Bromocriptine]]
 
* Surgical management:
** Endonasal transsphenoidal surgery
* [[Radiation therapy]]
|-
|[[ACTH-secreting tumor|Corticotroph adenoma]]: [[Cushing's syndrome]]
|Clinical features of [[Cushing's syndrome]] are due to increased levels of [[cortisol]]:
* Rapid [[Obesity|weight gain]], particularly of the [[trunk]] and face with sparing of the [[limbs]] ([[central obesity]])
* Proximal [[muscle weakness]]
* A round face often referred to as a "[[moon face]]"
* Excess [[sweating]]
* [[Headache]]
* The excess [[cortisol]] may also affect other endocrine systems and cause, for example:
** [[Insomnia]]
** Reduced [[libido]]
** [[Impotence]]
** [[Amenorrhea]]
** [[Infertility]]
* Patients frequently suffer various [[psychological]] disturbances, ranging from [[Euphoria (emotion)|euphoria]] to [[psychosis]]. [[Clinical depression|Depression]] and [[anxiety]] are also common.
|
* [[Dexamethasone suppression test]]
* 24 hour urinary measurement of [[cortisol]]
|
* Medical management:
** [[Pasireotide]]
** [[Cabergoline]]
** [[Ketoconazole]]
** [[Metyrapone]]
** [[Mitotane]]
** [[Mifepristone]]
* Surgical management:
** Transsphenoidal [[Pituitary gland|pituitary]] resection
|-
|[[Hypothyroidism]]
|Clinical features of [[hypothyroidism]] are due to deficiency of [[thyroxine]]:
* [[Fatigue]]


==Overview==
* Cold intolerance
* Decreased [[sweating]]
* [[Hypothermia]]
* Coarse [[skin]]
* [[Weight gain]]
* [[Hoarseness]]
* [[Goiter]]
 
* Fullness in the throat and neck
 
* [[Depression]]
 
* [[Emotional lability]]
* [[Attention deficit]]
|
* Elevated [[Thyroid-stimulating hormone|TSH]]
* Low [[Thyroxine|T4]]
* Low [[Triiodothyronine|T3]]
* Elevated anti-thyroid [[antibodies]](anti-TPO)
|[[Levothyroxine]]
|-
|[[Chronic renal failure]]
|There are no [[pathognomonic]] symptoms associated with [[chronic renal failure]]. Common non-specific symptoms of [[chronic renal failure]] include:
* [[Malaise]]
* [[Nausea]]
* Unintentional [[weight loss]]
* [[Pruritus]]
* [[Lower extremity edema]]
* [[Sleep disorders]]
|[[Urinalysis]]:
* [[Albuminuria]]
 
* [[Hematuria]]
* [[Pyuria]]
* [[Red blood cell|Red cell]] or [[White blood cells|white cell]] [[casts]] and crystals
[[Fluid and electrolytes|Fluid and electrolyte]] disturbances:
* [[Hyponatremia]]
* [[Hyperkalemia]]
* [[Hyperphosphatemia]]
* [[Hyperchloremia]]
* [[Metabolic acidosis]]
* [[Hypocalcemia]]
[[Endocrine system|Endocrine]] and [[metabolic]] disturbances:
* [[Hyperuricemia]]
* [[Hypertriglyceridemia]]
* Decreased [[HDL]] levels
* [[Vitamin D deficiency]]
* Increased [[Parathyroid hormone]] levels
[[Hematologic]] abnormalities:
* [[Normocytic normochromic anemia]]
* [[Lymphocytopenia]]
* [[Leukopenia]]
* [[Thrombocytopenia]]
 
|
* Medical management:
** [[Blood pressure medication|Blood pressure management]]
** Control of [[Blood sugar|blood glucose]]
** [[Protein]] restriction
** Management of [[anemia]]
** Management of [[electrolyte disturbance]]
** [[Dialysis]]
* Surgical management
** [[Kidney transplant]]
|-
|[[Cirrhosis|Liver disease: Cirrhosis]]
|The clinical features of liver [[cirrhosis]] are very nonspecific. These include:
* [[Right upper quadrant (abdomen)|Right upper quadrant]] [[abdominal pain]]
* [[Fever]]
* [[Fatigue]] and [[weakness]]
* [[Loss of appetite]]
* [[Diarrhea]]
* [[Nausea]] and [[vomiting]]
* [[Weight loss]]
* [[Abdominal pain]] and [[bloating]] when fluid accumulates in the [[abdomen]]
* [[Itching]]
* [[Menstrual cycle|Menstrual]] irregularities
|
*Elevated [[aminotransferases]] ([[Aspartate transaminase|AST]] & [[Alanine transaminase|ALT]])
*Elevated [[alkaline phosphatase]] ([[Alkaline phosphatase|ALP]])
 
*Elevated [[gamma-glutamyl transpeptidase]]
 
*Elevated [[bilirubin]]
 
*Low [[albumin]]
 
*Elevated [[prothrombin time]]
 
*Elevated [[globulin]]
 
*[[Hyponatremia]]
 
*[[Anemia]]
 
*[[Leukopenia]] and [[neutropenia]]
 
*[[Thrombocytopenia]]
 
|
* Medical management:
** Treatment is usually directed towards the treatment of complications like [[ascites]], [[esophageal varices]], [[hepatic encephalopathy]], [[hepatorenal syndrome]], and [[spontaneous bacterial peritonitis]].
*** Some chronic constitutional [[symptoms]] that should be treated include:
**** [[Pruritis]]: [[Cholestyramine]] is the drug of choice
**** [[Hypogonadism]]: Topical [[testosterone]] preparations
**** [[Osteoporosis]]: [[Calcium]] and [[vitamin D]]
**** Pain management: [[Non-steroidal anti-inflammatory drug|NSAIDS]], [[celecoxib]], [[opioids]]
**** Nutrition: Adequate [[Calories|caloric]] and [[protein]] intake, and [[multivitamin]] supplementation
* Surgical management: [[Liver transplantation]]
|-
|[[Seizure|Seizure disorder]]
|The clinical features of [[seizure disorder]] may include:
* Change in [[alertness]], orientation and time perception
 
* Mood changes, such as unexplainable fear, panic, joy, or laughter
* Changes in sensation of the [[skin]], usually spreading over the [[arm]], [[Leg (anatomy)|leg]], or [[trunk]]
* [[Vision]] changes, including seeing flashing lights
* Rarely, [[Hallucination|hallucinations]] (seeing things that aren't there)
* Falling, loss of [[muscle]] control, occurs very suddenly
* [[Muscle twitching]] that may spread up or down an [[arm]] or [[leg]]
* [[Muscle]] tension or tightening that causes twisting of the body, [[head]], [[Arm|arms]], or [[legs]]
* Shaking of the entire body
* Tasting a bitter or metallic flavor
|[[Electroencephalogram]]
|
* Medical management:
** [[Antiepileptics|Antiepileptic]] medications
|-
|[[Medication-induced]]
|Clinical features of [[hyperprolactinemia]] after a specific period of regular medication ingestion
|Discontinuation of the medication for 3 days and remeasurement of [[prolactin]] levels<ref name="pmid21296991">{{cite journal| author=Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA et al.| title=Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. | journal=J Clin Endocrinol Metab | year= 2011 | volume= 96 | issue= 2 | pages= 273-88 | pmid=21296991 | doi=10.1210/jc.2010-1692 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21296991  }}</ref>
|Change to alternate medication
|}
 
===Differentiating hypopituitarism on the basis of GH Deficiency===
 
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! rowspan="2" |Diseases
| rowspan="2" |History and symptoms
| colspan="4" |Physical Examination
! colspan="3" |Laboratory findings
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
!Puberty development
!Height velocity
!Parents height
!Characteristic facies
!Bone age
!Genetic analysis
!GH level
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Growth hormone deficiency<ref name="pmid10372687">{{cite journal| author=Colao A, Di Somma C, Pivonello R, Loche S, Aimaretti G, Cerbone G et al.| title=Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. | journal=J Clin Endocrinol Metab | year= 1999 | volume= 84 | issue= 6 | pages= 1919-24 | pmid=10372687 | doi=10.1210/jcem.84.6.5742 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10372687  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |
* Children: delayed [[developmental milestones]] and [[muscle weakness]]
* Adults: increased [[Body mass|lean body mass]], [[Osteopenia|osteopenia, and dyslipidemia]]
| style="background: #F5F5F5; padding: 5px;" |Delayed
| style="background: #F5F5F5; padding: 5px;" |Decreased
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |
* Doll-like fat distribution pattern
* Immature face with under developed [[nasal bridge]]
* Infantile voice
| style="background: #F5F5F5; padding: 5px;" |Dlayed
| style="background: #F5F5F5; padding: 5px;" |
* ''POU1F1'' gene mutations 
* GH1 gene mutations
| style="background: #F5F5F5; padding: 5px;" |Low
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Achondroplasia]]<ref name="pmid26182483">{{cite journal| author=Bouali H, Latrech H| title=Achondroplasia: Current Options and Future Perspective. | journal=Pediatr Endocrinol Rev | year= 2015 | volume= 12 | issue= 4 | pages= 388-95 | pmid=26182483 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26182483  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |
* Normal [[Intelligence test|Intelligence quotient]]
* A trunk of average size
* Arms and legs of diminished length
* [[Spinal stenosis]]
* [[Kyphosis]] and [[lordosis]]
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |Decreased
| style="background: #F5F5F5; padding: 5px;" |Decreased
| style="background: #F5F5F5; padding: 5px;" |
* Large heads
* Prominent forehead
* Midface hypoplasia
| style="background: #F5F5F5; padding: 5px;" |Delayed
| style="background: #F5F5F5; padding: 5px;" |
[[FGFR3 gene|FGFR3]] gene mutations
| style="background: #F5F5F5; padding: 5px;" |Normal
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Familial short stature<ref name="pmid24033502">{{cite journal| author=Kawashima Y, Hakuno F, Okada S, Hotsubo T, Kinoshita T, Fujimoto M et al.| title=Familial short stature is associated with a novel dominant-negative heterozygous insulin-like growth factor 1 receptor (IGF1R) mutation. | journal=Clin Endocrinol (Oxf) | year= 2014 | volume= 81 | issue= 2 | pages= 312-4 | pmid=24033502 | doi=10.1111/cen.12317 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24033502  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |
* A normal variant with normal signs, investigations
* Positive family history
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |Decreased
| style="background: #F5F5F5; padding: 5px;" |Decreased
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |[[Heterozygous]] ''[[IGF1]]'' [[Splicing]] [[mutation]]
| style="background: #F5F5F5; padding: 5px;" |Normal
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Constitutional growth delay<ref name="pmid21292259">{{cite journal| author=Vaaralahti K, Wehkalampi K, Tommiska J, Laitinen EM, Dunkel L, Raivio T| title=The role of gene defects underlying isolated hypogonadotropic hypogonadism in patients with constitutional delay of growth and puberty. | journal=Fertil Steril | year= 2011 | volume= 95 | issue= 8 | pages= 2756-8 | pmid=21292259 | doi=10.1016/j.fertnstert.2010.12.059 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21292259  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |
* Family history of [[Delayed growth;|delayed growth]] and [[puberty]]
* Childhood short stature but relatively normal adult height
* Normal size at birth
* A delayed growth rate begins at three to six months of age
 
* A family history of delayed growth and puberty in one or both parents
| style="background: #F5F5F5; padding: 5px;" |Delayed
 
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |Mutations in Variation in ''[[FGFR1]]'', ''[[GNRHR]], [[TAC 3|TAC3]],'' and ''TACR3 genes''
| style="background: #F5F5F5; padding: 5px;" |Normal
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Growth Hormone Resistance<ref name="pmid26062520">{{cite journal| author=Kurtoğlu S, Hatipoglu N| title=Growth hormone insensitivity: diagnostic and therapeutic approaches. | journal=J Endocrinol Invest | year= 2016 | volume= 39 | issue= 1 | pages= 19-28 | pmid=26062520 | doi=10.1007/s40618-015-0327-2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26062520  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |
* [[Growth hormone insensitivity syndrome|Growth hormone insensitivity]] is an absence of the biological effects of growth hormone despite a normal production of [[Growth hormone|GH]].
* Its severity correlates to [[IGF-I]] and [[Insulin-like growth factor-binding protein 1|insulin-like growth factor-binding protein]] 3 ([[IGFBP3|IGFBP]]-3) levels.
| style="background: #F5F5F5; padding: 5px;" |Delayed
| style="background: #F5F5F5; padding: 5px;" |Decreased
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |
* Small face in relation to head circumference
* Delayed dentition
| style="background: #F5F5F5; padding: 5px;" |Delayed
| style="background: #F5F5F5; padding: 5px;" |
* [[Growth hormone receptor]] mutations
* [[Insulin-like growth factor-I|IGF-I]] gene mutations
| style="background: #F5F5F5; padding: 5px;" |Normal
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hypothyroidism|Pediatric Hypothyroidism]]<ref name="pmid24662106">{{cite journal| author=Léger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G et al.| title=European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. | journal=Horm Res Paediatr | year= 2014 | volume= 81 | issue= 2 | pages= 80-103 | pmid=24662106 | doi=10.1159/000358198 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24662106  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |
* Low [[muscle tone]]
* Cold intolerance
* Persistent [[constipation]]
* [[Fatigue]] and [[weakness]]Excessive sleeping
* Exaggerated [[Neonatal jaundice|jaundice]]
| style="background: #F5F5F5; padding: 5px;" |Delayed
| style="background: #F5F5F5; padding: 5px;" |Decreased
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |
* Puffy facies
 
* [[Macroglossia]]
* Large fontanels
* [[Micrognathia]]
| style="background: #F5F5F5; padding: 5px;" |Delayed
| style="background: #F5F5F5; padding: 5px;" |
Mutations in:
* Paired box 8 [[PAX8 gene|(''PAX8)'']]
 
* Thyroid Transcription factor-2 (''TTF2''
* Transcription factors NK2
| style="background: #F5F5F5; padding: 5px;" |Normal
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Turner syndrome|Turner Syndrome]]<ref name="pmid25765448">{{cite journal| author=Trovó de Marqui AB| title=[Turner syndrome and genetic polymorphism: a systematic review]. | journal=Rev Paul Pediatr | year= 2015 | volume= 33 | issue= 3 | pages= 364-71 | pmid=25765448 | doi=10.1016/j.rpped.2014.11.014 | pmc=4620965 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25765448  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |
* Females only
* [[Infertility]]
* [[Webbed neck]]
* Widely spaced nipples
* Broad chest
* [[Genu valgum]]
* Short neck
* [[Ovarian failure]]  
| style="background: #F5F5F5; padding: 5px;" |Absent
| style="background: #F5F5F5; padding: 5px;" |Decreased
| style="background: #F5F5F5; padding: 5px;" |Decreased
| style="background: #F5F5F5; padding: 5px;" |
* Low hairline
* [[Low-set ears]]
* Characteristic facial features
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |45 X0
| style="background: #F5F5F5; padding: 5px;" |Normal
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Silver-Russell Syndrome]]<ref name="pmid21349887">{{cite journal| author=Wakeling EL| title=Silver-Russell syndrome. | journal=Arch Dis Child | year= 2011 | volume= 96 | issue= 12 | pages= 1156-61 | pmid=21349887 | doi=10.1136/adc.2010.190165 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21349887  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |
* [[Hemihypertrophy]]
 
* [[Hypoglycemia]]
* Wide fontanelle
* [[Clinodactyly]]
* [[Precocious puberty]]
| style="background: #F5F5F5; padding: 5px;" |Delayed
| style="background: #F5F5F5; padding: 5px;" |Decreased
| style="background: #F5F5F5; padding: 5px;" |Decreased
| style="background: #F5F5F5; padding: 5px;" |
* Prominent forehead
* Triangular face
* Downturned corners of the mouth
* [[Small jaw]]
* Pointed chin
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |[[Methylation]] involving the [[H19 (gene)|H19]] and [[Insulin-like growth factor 2|IGF2]] genes 
| style="background: #F5F5F5; padding: 5px;" |Normal
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Noonan syndrome|Noonan Syndrome]]<ref name="pmid17603482">{{cite journal| author=Razzaque MA, Nishizawa T, Komoike Y, Yagi H, Furutani M, Amo R et al.| title=Germline gain-of-function mutations in RAF1 cause Noonan syndrome. | journal=Nat Genet | year= 2007 | volume= 39 | issue= 8 | pages= 1013-7 | pmid=17603482 | doi=10.1038/ng2078 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17603482  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |
* [[Bleeding tendency]]
 
* [[Webbed neck]]
 
* [[Cryptorchidism]]
* [[Intellectual disability]]
| style="background: #F5F5F5; padding: 5px;" |Delayed
| style="background: #F5F5F5; padding: 5px;" |Decreased
| style="background: #F5F5F5; padding: 5px;" |Decreased
| style="background: #F5F5F5; padding: 5px;" |Minor [[facial dysmorphism]]
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |[[PTPN11 gene|PTPN11]] and [[SOS1]] genes abnormality
| style="background: #F5F5F5; padding: 5px;" |Normal
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Psychosocial Short Stature<ref name="pmid26210627">{{cite journal| author=Sandberg DE, Gardner M| title=Short Stature: Is It a Psychosocial Problem and Does Changing Height Matter? | journal=Pediatr Clin North Am | year= 2015 | volume= 62 | issue= 4 | pages= 963-82 | pmid=26210627 | doi=10.1016/j.pcl.2015.04.009 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26210627  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |
* A disorder of short stature or growth that is observed in association with emotional deprivation
* A disturbed relationship between child and caregiver is usually noted.
* A history of abuse or neglect and emotional deprivation
* The relationship between the caregiver and the child appears to be abnormal.
| style="background: #F5F5F5; padding: 5px;" |Delayed
| style="background: #F5F5F5; padding: 5px;" |Decreased
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |
* [[Failure to thrive]]
* [[Poor dental hygiene|Poor dental hygiene]]
* Sad Affect
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |May be low
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Short stature accompanying systemic disease<ref name="pmid24957008">{{cite journal| author=Sanderson IR| title=Growth problems in children with IBD. | journal=Nat Rev Gastroenterol Hepatol | year= 2014 | volume= 11 | issue= 10 | pages= 601-10 | pmid=24957008 | doi=10.1038/nrgastro.2014.102 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24957008  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |
* [[Growth failure]] is seen in children with systemic diseases such as [[chronic kidney disease]], [[malignancy]], [[Crohn's disease|Chron's disease,]] and [[Cushing's Disease|Cushing disease]].
* The primary causes of growth failure in children include [[metabolic acidosis]], poor nutrition secondary to dietary restrictions,  disturbances of growth hormone metabolism and its main mediator, [[insulin-like growth factor-I]] ([[Insulin-like growth factor-I|IGF-I)]].
| style="background: #F5F5F5; padding: 5px;" |Delayed
| style="background: #F5F5F5; padding: 5px;" |Decreased
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |Failure to thrive
| style="background: #F5F5F5; padding: 5px;" |Delayed
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |Normal
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Idiopathic short stature]]<ref name="pmid18182313">{{cite journal| author=Wit JM, Clayton PE, Rogol AD, Savage MO, Saenger PH, Cohen P| title=Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. | journal=Growth Horm IGF Res | year= 2008 | volume= 18 | issue= 2 | pages= 89-110 | pmid=18182313 | doi=10.1016/j.ghir.2007.11.004 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18182313  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |A height below 2 standard deviations (SD) of the mean for age, in the absence of any endocrine, metabolic, or other diagnosis
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |Decreased
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |Delayed
| style="background: #F5F5F5; padding: 5px;" |SHOX gene mutations<ref name="pmid26218795">{{cite journal| author=Ouni M, Castell AL, Rothenbuhler A, Linglart A, Bougnères P| title=Higher methylation of the IGF1 P2 promoter is associated with idiopathic short stature. | journal=Clin Endocrinol (Oxf) | year= 2015 | volume=  | issue=  | pages=  | pmid=26218795 | doi=10.1111/cen.12867 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26218795  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |Normal
|}
 
=== Differentiating hypopituitarism on the basis of ADH deficiency ===
{| class="wikitable"
! align="center" style="background: #4479BA; color: #FFFFFF; " |Type of DI
! align="center" style="background: #4479BA; color: #FFFFFF; " |Subclass
! align="center" style="background: #4479BA; color: #FFFFFF; " |Disease
! align="center" style="background: #4479BA; color: #FFFFFF; " |Defining signs and symptoms
! align="center" style="background: #4479BA; color: #FFFFFF; " |Lab/Imaging findings
|-
| rowspan="5" |Central
| rowspan="3" |Acquired
|[[Histiocytosis]]
|
* Bone lysis and [[Bone fracture|fracture]]
* Purulent [[otitis media]]
* [[Diabetes insipidus]] and delayed puberty
* [[Maxillary]], [[mandibular]], and [[gingival]] disease
* [[Rash]] and [[Erythematous|maculoerythematous]] skin lesions
* Scaly, [[erythematous]] scalp patches
* [[Lung]] involvement
* [[GI bleeding]]
* [[Lymphadenopathy|Lymph node enlargement]]<ref name="pmid1340034">{{cite journal| author=Ghosh KN, Bhattacharya A| title=Gonotrophic nature of Phlebotomus argentipes (Diptera: Psychodidae) in the laboratory. | journal=Rev Inst Med Trop Sao Paulo | year= 1992 | volume= 34 | issue= 2 | pages= 181-2 | pmid=1340034 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1340034  }} </ref>
|
* CD1a and CD45 +
* Interleukin-17 (ILITA)
|-
|[[Craniopharyngioma]]
|
* [[Headache]]
* [[Endocrine disorders|Endocrine dysfunction]]
** [[Diabetes insipidus]]
** [[Hypothyroidism]]
** [[Adrenal failure]]
** [[Diabetes insipidus]] (eg, excessive fluid intake and urination)
** Growth failure and [[delayed puberty]]
|
* [[Suprasellar]] calcified cyst on [[MRI]]
|-
|[[Sarcoidosis]]
|
* Systemic complaints
** [[Fever]]
** [[Anorexia]]
** [[Arthralgias]]
* Pulmonary complaints
** [[Dyspnea on exertion]]
** [[Cough]]
** Chest pain,
** [[Hemoptysis]] (rare)
* [[Diabetes mellitus]]
|
* [[Hypercalcemia]]
* [[Hypercalciuria]] ([[Granulomas|noncaseating granulomas]])
* Elevated [[alkaline phosphatase]]
* [[Serum amyloid A]] (SAA)
* [[Angiotensin-converting enzyme|ACE]] levels may be elevated
|-
| rowspan="2" |Congenital
|[[Hydrocephalus]]
|
* Cognitive deterioration
* [[Headaches]]
* [[Neck pain]]
* [[Blurred vision]]
* [[Unsteady gait]]
* [[Incontinence]] such as [[polyuria]]
|Dilated [[ventricles]] on [[Computed tomography|CT]] and [[Magnetic resonance imaging|MRI]]
|-
|[[Wolfram syndrome|Wolfram Syndrome]] (DIDMOAD)
|
* [[Diabetes insipidus|Diabetes Insipidus]]
* [[Diabetes mellitus|Diabetes Mellitus]]
* [[Optic atrophy|Optic Atrophy]]
* [[Deafness]]
|
* Negative [[islet cell]] antibodies
* [[Optic atrophy]] on [[electroretinogram]]
* [[Deafness]] on [[audiogram]]
* [[Atrophy]] of brain stem on [[Magnetic resonance imaging|MRI]]
|-
| rowspan="5" |[[Nephrogenic diabetes insipidus|Nephrogenic]]
| rowspan="5" |[[Acquired disorder|Acquired]]
|Drug-induced ([[demeclocycline]], [[lithium]])
|
* [[Polyuria]]
* [[Polydipsia]]
* [[Nocturia]]
|
* [[Urine osmolality]] <100 mmol/
* [[Arginine vasopressin]] level >4.6 pmol/
* little or no response to administration of  exogenous [[arginine vasopressin]]
|-
|[[Hypercalcemia]]
|
* [[Polyuria]]
* [[Polydipsia]]
* [[Gastrointestinal]] disturbances
* [[Bone fracture|Pathological fractures]]
* [[Confusion]]
* [[Palpitations]] and [[cardiac arrhythmias]]
|
* Ca levels greater than 11 meq/L
|-
|[[Hypokalemia]]
|
* [[Polyuria]]
* [[Hyporeflexia]]
* [[Palpitations]] and [[cardiac arrhythmias]]
|
* K levels less than 3meq/L on CBC
|-
|[[Multiple myeloma]]
|
* Pathologic [[bone fractures]]
* [[Bleeding]]
* [[Hypercalcemia]] leading to [[polyuria]]
* [[Infection]]
* [[Hyperviscosity]]
* [[Anemia]]
|
* [[IgG]] or [[IgA]] spike on [[serum protein electrophoresis]]
* [[Monoclonal antibody|Monoclonal M spike]]
* Disordered [[plasma cell]] proliferation on [[bone marrow biopsy]]
|-
|[[Sickle-cell disease|Sickle cell disease]]
|
* [[Chronic pain]]
* [[Anemia]]
* [[Aplastic crisis]]
* Splenic sequestration
* [[Infection]]
* [[Isosthenuria]] presenting with [[polyuria]]
|
* [[Hemoglobin]] level is 5-9 g/dL
* [[Hematocrit]] is decreased to 17-29%
* [[Peripheral blood smear|Peripheral blood smears]] demonstrate [[Target cell|target cells]], elongated cells, and characteristic sickle erythrocytes
* MRI can demonstrate [[avascular necrosis]] of the [[femoral]] and [[humeral]] heads
|-
| colspan="2" |Primary polydipsia
|[[Psychogenic]]
|
* [[Polyuria]]
* [[Polydipsia]]
* [[Nocturia]]
|
* Dry mucus membrane
* History of [[psychiatric disorders]]
|-
| colspan="3" |Gestational diabetes insipidus
|
* [[Polyuria]]
* [[Polydipsia]]
* [[Nocturia]]
* [[Pregnancy]]
|
* Dry mucus membranes
* [[Pregnancy]]
|-
| colspan="3" |[[Diabetes mellitus]]
|
* [[Polyuria]]
* [[Polydipsia]]
* [[Nocturia]]
* [[Weight gain (patient information)|Weight gain]]
|
* Elevated blood sugar levels >126
* Elevated [[HbA1c]] > 6.5
|}
 
Hypopituitarism must be differentiated from other causes of headache, polyuria and polydypsia.
{| class="wikitable"
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Causes
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Symptoms
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Diagnosis and treatment
|- Diagnostic criteria of SIADH include:
 
|[[SIADH]]
|[[SIADH]] is a syndrome characterized by excessive release of [[Vasopressin|antidiuretic hormone]] (ADH or vasopressin) from the [[posterior pituitary]] gland or another source. The result is [[hyponatremia]], and sometimes [[fluid]] overload
|
*[[Nausea]] / [[vomiting]]
*[[Cramps]]
*[[Depressed mood]]
*[[Irritability]]
*[[Confusion]]
*[[ Hallucinations]]
*[[Seizures]], [[stupor]] or [[coma ]]
|
*[[Hyponatremia ]] <135 mmol/l
 
*Effective serum [[osmolality]]<275mosm
 
*Urine [[sodium]] concentration>40mmol/litre
 
*Plasma [[uric acid]] <200;FeUrate>12%
 
*Absence of [[Edematous malnutrition|edematous]] disease like[[ cardiac failure]], [[liver cirrhosis]],[[ nephrotic syndrome]].
 
*Normal [[adrenal]] and [[thyroid]] function
 
|-
|[[Cerebral salt wasting syndrome]]
 
|[[ Cerebral salt wasting syndrome]] is defined as the[[ renal]] loss of [[sodium]] during [[Intracranial Bleeding|intracranial]] [[disease]] leading to [[hyponatremia]] and a decrease in extracellular [[fluid]] volume
 
*[[Trauma]]
*[[Tumor]]
*[[Hematoma]]
 
|The patient is
*[[Hypovolemic]]
*[[Hyponatremia|Hyponatremic]]
 
|Treatment is
*[[Hydration]] and
*[[Sodium]] replacement
|-
|[[Adrenal insufficiency]]
 
|[[Adrenal insufficiency]]
* [[ Mineralocorticoid deficiency]] is present. [[Secondary]] or [[tertiary adrenal insufficiency]] will  have preserved[[ mineralocorticoid]] function owing to  separate feedback mechanisms
Adrenal insufficiency can be
*[[Primary]]
*[[Secondary]]
*[[Tertiary]]
 
Common causes of primary [[adrenal]] insufficiency:
*[[Autoimmune]]
*[[Iatrogenic]]
*[[Drugs]]
* [[Adrenal hemorrhage]]
*[[Cancer]]
*[[Infection]]
*[[Congenital]]
*Secondary [[Adrenal gland|adrenal]] insufficiency: ( [[Aldosterone]]) levels normal
*Most common causes are:
*[[Traumatic brain injury (TBI) ]]
*[[Panhypopituitarism]] 
*Tertiary [[Adrenal gland|adrenal]] insufficiency
*Exogenous[[ steroid]] administration is the most common cause of tertiary [[adrenal]] insufficiency
|
* [[Fatigue]]
*[[ Muscle weakness]]
* [[Loss of appetite]]
*[[ Weight loss]]
* [[Abdominal pain]]
*[[Diarrhea]]
*[[Vomiting]]
 
Chronic disease is characterized by
*[[Weight loss]]
*Sparse [[axillary]] hair
*[[Hyperpigmentation]]
*[[Orthostatic hypotension]].
 
Acute [[addisonian]] crisis is characterized by:
*[[Fever]]
*[[ Hypotension]]
|The diagnosis of [[Addisons]] disease is made through rapid [[ACTH]] administration and measurement of [[cortisol]].
*Lab findings include:
*[[White blood cell]] count with moderate [[neutropenia]]
*[[Lymphocytosis]]
*[[ Eosinophilia]]
*[[Hyperkalemia]]
* [[Hypoglycemia]]
*[[Hyponatremia]]
* Morning low plasma [[cortisol]].
The definitive diagnosis is the [[cosyntropin]] or [[ACTH]] stimulation test. A[[ cortisol]] level is obtained before and after administering [[ACTH]]. A normal person should show a brisk rise in [[cortisol]] level after [[ACTH]] administration.
 
 
Management: The management of [[Addison]] [[disease]] involves:
*[[Gluocorticoid]]
*[[Mineralocorticoid]]
*[[Sodium chloride]] replacement.
[[Adrenal gland|Adrenal]] crisis:
*In adrenal crisis,measure [[cortisol]] level,then rapidly administer
*[[ Fluids]]
*[[ Hydrocortisone]] 
|-
|[[Hypopituitarism]]
| Abnormality in [[anterior pituitary]] function
Etiology is as follows:
*[[Pituitary]] [[tumors]]
*[[Sellar tumors]]
*[[Head trauma]]
*[[Infection]]
*[[Empty sella]]
*[[Infiltration]]
*Idiopathic
*[[Congenital]]
|
[[Signs]] and [[symptoms]] of[[ hypopituitarism]] vary, depending on the deficient
 
[[hormone ]] and severity of the disorder,some of the [[symptoms]] may be as follows:
* [[Fatigue]]
* [[Weight loss]]
* Decreased [[libido]]
* Decreased [[appetite]]
* Facial [[puffiness]]
* [[Anemia]]
* [[Infertility]]
*[[ Cold insensitivity]].
* [[Amenorrha]]
*[[Inability to lactate]] in [[breast feeding]] women
* Decreased [[facial]] or[[ body hair]] in men
* [[Short stature]] in children
|
* [[History]] and[[ physical examination]], including [[visual field]] testing, are important.
 
The [[Treatment-resistant depression|treatment]] of permanent [[hypopituitarism]] consists of replacement of the peripheral [[hormones]]
*[[Hydrocortisone]]
*[[DHEA]]
*[[Thyroxine]]
*[[Testosterone]] or [[oestradiol]]
*[[ Growth hormone]]
*[[Surgery]] and/or
*[[ Radiotherapy]] to restore normal [[endocrine]] function and quality of life
*Life long [[Monitoring competence|monitoring]] of serum [[hormone]] levels and [[symptoms]] of hormone deficiency or excess is needed in these [[patients]]
|-
|[[Hypothyroidism]]
|Hypofunctioning of the thyroid gland due to multifactorial etiology ranging from congenital to [[autoimmune]] causes described below:
*[[Congenital]]
*[[Autoimmune]]
*[[Drugs]]
*Post [[surgery]]
*Post [[radiation]]
*Infiltrative e.g., [[amyloid]]
|
*[[ Fatigue]]
* [[Constipation]]
*[[ Dry skin]]
*[[ Weight gain]]
* [[Cold intolerance]]
*[[ Puffy face]]
*[[ Hoarseness]]
*[[ Muscle weakness]]
* Elevated blood [[cholesterol]] level
* [[Bradycardia]]
*[[ Myopathy]]
*[[ Depression]]
* Impaired [[memory]]
| Diagnosis of [[hypothyroidism]] is based on [[blood]] tests:
*T3([[triiodothyronine]])
*T4([[Thyroxine]]) and
*TSH ([[thyroid]] stimulating hormone).
*Signs and [[symptoms]] are neither [[sensitive]] nor [[specific]] for the [[diagnosis]].
*[[TSH]] is the most [[Sensitive Skin|sensitive]] tool for [[Screening (medicine)|screening]],diagnosis and [[Treatment-resistant depression|treatment]] follow up, when[[ pituitary]] is normal.
*The [[drug]] of choice for treatment is [[Levothyroxine]]
|-
|[[Psychogenic polydipsia]]
| Also called as primary [[polydipsia]] is characterized by[[ polyuria]] and [[polydipsia]]. Causes are:
 
*Adverse effect of a [[medication]]
*Traumatic[[ brain]] injury
*[[Psychiatric]] disorders such as [[schizophrenia]]
* Defect in the [[hypothalamus]]
|
*[[Polyuria]]
*[[Polydipsia]]
*[[Confusion]]
*[[Lethargy]]
*[[Psychosis]]
*[[Seizures]] and
*Sometimes, even death
|Evaluation of[[ psychiatric]] patients with [[polydipsia]] requires an evaluation for other medical causes of polydipsia, [[polyuria]],[[ hyponatremia]], and the syndrome of inappropriate secretion of [[antidiuretic]] hormone.
*The management strategy in[[ psychiatric]] patients should include:
 
*[[Fluid]] restriction and[[ behavioral]] and [[pharmacologic]] modalities.
*The water deprivation test is the [[gold standard]] test
|}


==Differential Diagnosis==


==References==
==References==
​​
{{Reflist|2}}
{{Reflist|2}}


[[Category:Needs content]]
[[Category:Medicine]]
[[Category:Disease]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]
 
[[Category:Up-To-Date]]
{{WH}}
{{WS}}

Latest revision as of 22:19, 29 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Iqra Qamar M.D.[2], Ahmed Elsaiey, MBBCH [3]

Overview

Hypopituitarism should be differentiated from other diseases causing panhypopituitarism, hypothyroidism, hypogonadism, ACTH deficiency, GH deficiency, ADH deficiency and high prolactin level.

Differentiating Hypopituitarism From Other Diseases

Differentiating various causes of Panhypopituitarism

Hypopituitarism should be differentiated from other diseases causing panhypopituitarism, hypothyroidism, hypogonadism, ACTH deficiency, GH deficiency, ADH deficiency and high prolactin level.[1][2][3][4][5][6][7]

Diseases Onset Manifestations Diagnosis
History and Symptoms Physical examination Laboratory findings Gold standard Imaging Other investigation findings
Trumatic delivery Lactation failure Menstrual irregularities Other features
Panhypopituitarism Chronic - + Oligo/amenorrhea
  • All pituitary hormones decreased
Sheehan's syndrome Acute ++ ++ Oligo/amenorrhea
  • Dx is clinical
  • Most sensitive test: low baseline prolactin levels w/o response to TRH
CT/MRI:
  • Sequential changes of pituitary enlargement followed by
  • Shrinkage and necrosis leading to decreased sellar volume or empty sella
Lymphocytic hypophysitis Acute +/- + Oligo/amenorrhea
  • Retro-orbital or Bitemporal pain
  • Diffuse and homogeneous contrast enhancement
Assays for:
  • Anti-TPO
  • Anti-Tg Ab
Pituitary apoplexy Acute +/- ++ Oligo/amenorrhea Severe headache
  • Decreased levels of anterior pituitary hormones in blood.
  • CT scan without contrast: Hemorrhage on CT presents as a hyperdense lesion

Blood tests may be done to check:

Empty sella syndrome Chronic - + Oligo/amenorrhea
  • Decreased levels of pituitary hormones in blood.
Simmond's disease/Pituitary cachexia Chronic +/- + Oligo/amenorrhea
  • Loss of body hair
  • Decreased levels of anterior pituitary hormones in blood.

Differentiating hypopituitarism from hypothyroidism that present as a single hormonal deficiency

[8] [9][10][11]

Disease History and symptoms Laboratory findings Additional findings
Fever Goiter Pain TSH Free T4 T3 T3RU Thyroglobin TRH TPOAb
Primary hypothyroidism Autoimmune + +/-

Diffuse

- N/ Normal N/ Normal
Thyroiditis + +/- + Normal Normal N/ Normal Normal
Others - +/- - Normal Normal N/ Normal Normal
Transient hypothyroidism +/- - +/- Normal Normal Normal Normal
Subclinical hypothyroidism - - - Normal Normal Normal Normal N/
  • Asymptomatic
Central Hypothyroidism Pituitary + - - N/ N/ N/ Normal Normal Normal
Hypothalamus + - - Normal Normal
Resistance to TSH/TRH - - - N/ N/ Normal Normal / Normal
  • Rare

Legend:'TSH: Thyroid stimulating hormone, T4: Teraiodothyronine, T3: Triiodothyronine, T3RU: Triiodothyronine reuptake, TRH: Thyrotrophin releasing hormone, TPOAb: Thyroid peroxidase antibody, N: Normal, +: Present, -: Absent

Differentiating hypopituitarism on the basis of Gonadotropins (FSH/LH) deficiency

[12][13][14][15][16][17][18][19][20][21]

Diseases Clinical findings Diagnosis Manangement
Congenital diseases Klinefelter syndrome Clinical features of Klinefelter syndrome are as the following:[12]
  • Language learning impairment.
Kallmann syndrome Clinical features of Kallmann syndrome include:

Differentiating hypopituitarism on the basis of High prolactin level

[22][23][24][25][26][27][28][29][30]

Disease Clinical Findings Laboratory findings Management
Somatotroph adenoma:

Acromegaly

Clinical features of acromegaly are due to high level of human growth hormone (hGH):
Corticotroph adenoma: Cushing's syndrome Clinical features of Cushing's syndrome are due to increased levels of cortisol:
Hypothyroidism Clinical features of hypothyroidism are due to deficiency of thyroxine:
  • Fullness in the throat and neck
Levothyroxine
Chronic renal failure There are no pathognomonic symptoms associated with chronic renal failure. Common non-specific symptoms of chronic renal failure include: Urinalysis:

Fluid and electrolyte disturbances:

Endocrine and metabolic disturbances:

Hematologic abnormalities:

Liver disease: Cirrhosis The clinical features of liver cirrhosis are very nonspecific. These include:
Seizure disorder The clinical features of seizure disorder may include:
  • Change in alertness, orientation and time perception
  • Mood changes, such as unexplainable fear, panic, joy, or laughter
  • Changes in sensation of the skin, usually spreading over the arm, leg, or trunk
  • Vision changes, including seeing flashing lights
  • Rarely, hallucinations (seeing things that aren't there)
  • Falling, loss of muscle control, occurs very suddenly
  • Muscle twitching that may spread up or down an arm or leg
  • Muscle tension or tightening that causes twisting of the body, head, arms, or legs
  • Shaking of the entire body
  • Tasting a bitter or metallic flavor
Electroencephalogram
Medication-induced Clinical features of hyperprolactinemia after a specific period of regular medication ingestion Discontinuation of the medication for 3 days and remeasurement of prolactin levels[31] Change to alternate medication

Differentiating hypopituitarism on the basis of GH Deficiency

Diseases History and symptoms Physical Examination Laboratory findings
Puberty development Height velocity Parents height Characteristic facies Bone age Genetic analysis GH level
Growth hormone deficiency[32] Delayed Decreased Normal
  • Doll-like fat distribution pattern
  • Immature face with under developed nasal bridge
  • Infantile voice
Dlayed
  • POU1F1 gene mutations 
  • GH1 gene mutations
Low
Achondroplasia[33] Normal Decreased Decreased
  • Large heads
  • Prominent forehead
  • Midface hypoplasia
Delayed

FGFR3 gene mutations

Normal
Familial short stature[34]
  • A normal variant with normal signs, investigations
  • Positive family history
Normal Decreased Decreased Normal Normal Heterozygous IGF1 Splicing mutation Normal
Constitutional growth delay[35]
  • Family history of delayed growth and puberty
  • Childhood short stature but relatively normal adult height
  • Normal size at birth
  • A delayed growth rate begins at three to six months of age
  • A family history of delayed growth and puberty in one or both parents
Delayed Normal Normal Normal Normal Mutations in Variation in FGFR1GNRHR, TAC3, and TACR3 genes Normal
Growth Hormone Resistance[36] Delayed Decreased Normal
  • Small face in relation to head circumference
  • Delayed dentition
Delayed Normal
Pediatric Hypothyroidism[37] Delayed Decreased Normal
  • Puffy facies
Delayed

Mutations in:

  • Thyroid Transcription factor-2 (TTF2
  • Transcription factors NK2
Normal
Turner Syndrome[38] Absent Decreased Decreased Normal 45 X0 Normal
Silver-Russell Syndrome[39] Delayed Decreased Decreased
  • Prominent forehead
  • Triangular face
  • Downturned corners of the mouth
  • Small jaw
  • Pointed chin
Normal Methylation involving the H19 and IGF2 genes  Normal
Noonan Syndrome[40] Delayed Decreased Decreased Minor facial dysmorphism Normal PTPN11 and SOS1 genes abnormality Normal
Psychosocial Short Stature[41]
  • A disorder of short stature or growth that is observed in association with emotional deprivation
  • A disturbed relationship between child and caregiver is usually noted.
  • A history of abuse or neglect and emotional deprivation
  • The relationship between the caregiver and the child appears to be abnormal.
Delayed Decreased Normal Normal Normal May be low
Short stature accompanying systemic disease[42] Delayed Decreased Normal Failure to thrive Delayed Normal Normal
Idiopathic short stature[43] A height below 2 standard deviations (SD) of the mean for age, in the absence of any endocrine, metabolic, or other diagnosis Normal Decreased Normal Normal Delayed SHOX gene mutations[44] Normal

Differentiating hypopituitarism on the basis of ADH deficiency

Type of DI Subclass Disease Defining signs and symptoms Lab/Imaging findings
Central Acquired Histiocytosis
  • CD1a and CD45 +
  • Interleukin-17 (ILITA)
Craniopharyngioma
Sarcoidosis
Congenital Hydrocephalus Dilated ventricles on CT and MRI
Wolfram Syndrome (DIDMOAD)
Nephrogenic Acquired Drug-induced (demeclocycline, lithium)
Hypercalcemia
  • Ca levels greater than 11 meq/L
Hypokalemia
  • K levels less than 3meq/L on CBC
Multiple myeloma
Sickle cell disease
Primary polydipsia Psychogenic
Gestational diabetes insipidus
Diabetes mellitus
  • Elevated blood sugar levels >126
  • Elevated HbA1c > 6.5

Hypopituitarism must be differentiated from other causes of headache, polyuria and polydypsia.

Disease Causes Symptoms Diagnosis and treatment
SIADH SIADH is a syndrome characterized by excessive release of antidiuretic hormone (ADH or vasopressin) from the posterior pituitary gland or another source. The result is hyponatremia, and sometimes fluid overload
  • Urine sodium concentration>40mmol/litre
Cerebral salt wasting syndrome Cerebral salt wasting syndrome is defined as therenal loss of sodium during intracranial disease leading to hyponatremia and a decrease in extracellular fluid volume The patient is Treatment is
Adrenal insufficiency Adrenal insufficiency

Adrenal insufficiency can be

Common causes of primary adrenal insufficiency:

Chronic disease is characterized by

Acute addisonian crisis is characterized by:

The diagnosis of Addisons disease is made through rapid ACTH administration and measurement of cortisol.

The definitive diagnosis is the cosyntropin or ACTH stimulation test. Acortisol level is obtained before and after administering ACTH. A normal person should show a brisk rise in cortisol level after ACTH administration.


Management: The management of Addison disease involves:

Adrenal crisis:

Hypopituitarism Abnormality in anterior pituitary function

Etiology is as follows:

Signs and symptoms ofhypopituitarism vary, depending on the deficient

hormone and severity of the disorder,some of the symptoms may be as follows:

The treatment of permanent hypopituitarism consists of replacement of the peripheral hormones

Hypothyroidism Hypofunctioning of the thyroid gland due to multifactorial etiology ranging from congenital to autoimmune causes described below: Diagnosis of hypothyroidism is based on blood tests:
Psychogenic polydipsia Also called as primary polydipsia is characterized bypolyuria and polydipsia. Causes are: Evaluation ofpsychiatric patients with polydipsia requires an evaluation for other medical causes of polydipsia, polyuria,hyponatremia, and the syndrome of inappropriate secretion of antidiuretic hormone.
  • The management strategy inpsychiatric patients should include:


References

​​

  1. Sato N, Sze G, Endo K (1998). "Hypophysitis: endocrinologic and dynamic MR findings". AJNR Am J Neuroradiol. 19 (3): 439–44. PMID 9541295.
  2. Powrie JK, Powell M, Ayers AB, Lowy C, Sönksen PH (1995). "Lymphocytic adenohypophysitis: magnetic resonance imaging features of two new cases and a review of the literature". Clin. Endocrinol. (Oxf). 42 (3): 315–22. PMID 7758238.
  3. Honegger J, Schlaffer S, Menzel C, Droste M, Werner S, Elbelt U, Strasburger C, Störmann S, Küppers A, Streetz-van der Werf C, Deutschbein T, Stieg M, Rotermund R, Milian M, Petersenn S (2015). "Diagnosis of Primary Hypophysitis in Germany". J. Clin. Endocrinol. Metab. 100 (10): 3841–9. doi:10.1210/jc.2015-2152. PMID 26262437.
  4. Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E, Ezzat S (1995). "Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings". J. Clin. Endocrinol. Metab. 80 (8): 2302–11. doi:10.1210/jcem.80.8.7629223. PMID 7629223.
  5. Imura H, Nakao K, Shimatsu A, Ogawa Y, Sando T, Fujisawa I, Yamabe H (1993). "Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus". N. Engl. J. Med. 329 (10): 683–9. doi:10.1056/NEJM199309023291002. PMID 8345854.
  6. Hsieh CY, Liu BY, Yang YN, Yin WH, Young MS (2011). "Massive pericardial effusion with diastolic right ventricular compression secondary to hypothyroidism in a 73-year-old woman". Emerg Med Australas. 23 (3): 372–5. doi:10.1111/j.1742-6723.2011.01425.x. PMID 21668725.
  7. Dejager S, Gerber S, Foubert L, Turpin G (1998). "Sheehan's syndrome: differential diagnosis in the acute phase". J. Intern. Med. 244 (3): 261–6. PMID 9747750.
  8. Colon-Otero G, Menke D, Hook CC (1992). "A practical approach to the differential diagnosis and evaluation of the adult patient with macrocytic anemia". Med. Clin. North Am. 76 (3): 581–97. PMID 1578958.
  9. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT (2005). "Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society". J. Clin. Endocrinol. Metab. 90 (1): 581–5, discussion 586–7. doi:10.1210/jc.2004-1231. PMID 15643019.
  10. Rugge JB, Bougatsos C, Chou R (2015). "Screening and treatment of thyroid dysfunction: an evidence review for the U.S. Preventive Services Task Force". Ann. Intern. Med. 162 (1): 35–45. doi:10.7326/M14-1456. PMID 25347444.
  11. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA (2012). "Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association". Thyroid. 22 (12): 1200–35. doi:10.1089/thy.2012.0205. PMID 22954017.
  12. 12.0 12.1 Denschlag, Dominik, MD; Clemens, Tempfer, MD; Kunze, Myriam, MD; Wolff, Gerhard, MD; Keck, Christoph, MD (October 2004), "Assisted reproductive techniques in patients with Klinefelter syndrome: A critical review", Fertility and Sterility, 82 (4): 775–779, doi:10.1016/j.fertnstert.2003.09.085
  13. Virtanen HE, Bjerknes R, Cortes D, Jørgensen N, Rajpert-De Meyts E, Thorsson AV; et al. (2007). "Cryptorchidism: classification, prevalence and long-term consequences". Acta Paediatr. 96 (5): 611–6. doi:10.1111/j.1651-2227.2007.00241.x. PMID 17462053.
  14. Schmitz D, Safranek S (2009). "Clinical inquiries. How useful is a physical exam in diagnosing testicular torsion?". J Fam Pract. 58 (8): 433–4. PMID 19679025.
  15. Trojian TH, Lishnak TS, Heiman D (2009). "Epididymitis and orchitis: an overview". Am Fam Physician. 79 (7): 583–7. PMID 19378875.
  16. Stewart A, Ubee SS, Davies H (2011). "Epididymo-orchitis". BMJ. 342: d1543. PMID 21490048.
  17. Christine Cortet-Rudelli, Didier Dewailly (2006). "Diagnosis of Hyperandrogenism in Female Adolescents". Hyperandrogenism in Adolescent Girls. Armenian Health Network, Health.am. Unknown parameter |month= ignored (help)
  18. Legro RS, Barnhart HX, Schlaff WD (2007). "Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome". N Engl J Med. 356 (6): 551–566. PMID 17287476.
  19. Brunham RC, Gottlieb SL, Paavonen J (2015). "Pelvic inflammatory disease". N. Engl. J. Med. 372 (21): 2039–48. doi:10.1056/NEJMra1411426. PMID 25992748.
  20. Ford GW, Decker CF (2016). "Pelvic inflammatory disease". Dis Mon. 62 (8): 301–5. doi:10.1016/j.disamonth.2016.03.015. PMID 27107781.
  21. Murphy AA (2002). "Clinical aspects of endometriosis". Ann N Y Acad Sci. 955: 1–10, discussion 34-6, 396–406. PMID 11949938.
  22. Rigg LA, Lein A, Yen SS (1977). "Pattern of increase in circulating prolactin levels during human gestation". Am J Obstet Gynecol. 129 (4): 454–6. PMID 910825.
  23. Levy A (2004). "Pituitary disease: presentation, diagnosis, and management". J Neurol Neurosurg Psychiatry. 75 Suppl 3: iii47–52. doi:10.1136/jnnp.2004.045740. PMC 1765669. PMID 15316045.
  24. Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH (1973). "Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone". J Clin Invest. 52 (9): 2324–9. doi:10.1172/JCI107421. PMC 333037. PMID 4199418.
  25. Jha SK, Kannan S (2016). "Serum prolactin in patients with liver disease in comparison with healthy adults: A preliminary cross-sectional study". Int J Appl Basic Med Res. 6 (1): 8–10. doi:10.4103/2229-516X.173984. PMC 4765284. PMID 26958514.
  26. Ben-Menachem, Elinor (2006). "Is Prolactin a Clinically Useful Measure of Epilepsy?". Epilepsy Currents. 6 (3): 78–79. doi:10.1111/j.1535-7511.2006.00104.x. ISSN 1535-7597.
  27. Trimble MR (1978). "Serum prolactin in epilepsy and hysteria". Br Med J. 2 (6153): 1682. PMC 1608938. PMID 737437.
  28. David SR, Taylor CC, Kinon BJ, Breier A (2000). "The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia". Clin Ther. 22 (9): 1085–96. doi:10.1016/S0149-2918(00)80086-7. PMID 11048906.
  29. McCallum RW, Sowers JR, Hershman JM, Sturdevant RA (1976). "Metoclopramide stimulates prolactin secretion in man". J Clin Endocrinol Metab. 42 (6): 1148–52. doi:10.1210/jcem-42-6-1148. PMID 777023.
  30. Steiner J, Cassar J, Mashiter K, Dawes I, Fraser TR, Breckenridge A (1976). "Effects of methyldopa on prolactin and growth hormone". Br Med J. 1 (6019): 1186–8. PMC 1639736. PMID 1268617.
  31. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA; et al. (2011). "Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline". J Clin Endocrinol Metab. 96 (2): 273–88. doi:10.1210/jc.2010-1692. PMID 21296991.
  32. Colao A, Di Somma C, Pivonello R, Loche S, Aimaretti G, Cerbone G; et al. (1999). "Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism". J Clin Endocrinol Metab. 84 (6): 1919–24. doi:10.1210/jcem.84.6.5742. PMID 10372687.
  33. Bouali H, Latrech H (2015). "Achondroplasia: Current Options and Future Perspective". Pediatr Endocrinol Rev. 12 (4): 388–95. PMID 26182483.
  34. Kawashima Y, Hakuno F, Okada S, Hotsubo T, Kinoshita T, Fujimoto M; et al. (2014). "Familial short stature is associated with a novel dominant-negative heterozygous insulin-like growth factor 1 receptor (IGF1R) mutation". Clin Endocrinol (Oxf). 81 (2): 312–4. doi:10.1111/cen.12317. PMID 24033502.
  35. Vaaralahti K, Wehkalampi K, Tommiska J, Laitinen EM, Dunkel L, Raivio T (2011). "The role of gene defects underlying isolated hypogonadotropic hypogonadism in patients with constitutional delay of growth and puberty". Fertil Steril. 95 (8): 2756–8. doi:10.1016/j.fertnstert.2010.12.059. PMID 21292259.
  36. Kurtoğlu S, Hatipoglu N (2016). "Growth hormone insensitivity: diagnostic and therapeutic approaches". J Endocrinol Invest. 39 (1): 19–28. doi:10.1007/s40618-015-0327-2. PMID 26062520.
  37. Léger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G; et al. (2014). "European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism". Horm Res Paediatr. 81 (2): 80–103. doi:10.1159/000358198. PMID 24662106.
  38. Trovó de Marqui AB (2015). "[Turner syndrome and genetic polymorphism: a systematic review]". Rev Paul Pediatr. 33 (3): 364–71. doi:10.1016/j.rpped.2014.11.014. PMC 4620965. PMID 25765448.
  39. Wakeling EL (2011). "Silver-Russell syndrome". Arch Dis Child. 96 (12): 1156–61. doi:10.1136/adc.2010.190165. PMID 21349887.
  40. Razzaque MA, Nishizawa T, Komoike Y, Yagi H, Furutani M, Amo R; et al. (2007). "Germline gain-of-function mutations in RAF1 cause Noonan syndrome". Nat Genet. 39 (8): 1013–7. doi:10.1038/ng2078. PMID 17603482.
  41. Sandberg DE, Gardner M (2015). "Short Stature: Is It a Psychosocial Problem and Does Changing Height Matter?". Pediatr Clin North Am. 62 (4): 963–82. doi:10.1016/j.pcl.2015.04.009. PMID 26210627.
  42. Sanderson IR (2014). "Growth problems in children with IBD". Nat Rev Gastroenterol Hepatol. 11 (10): 601–10. doi:10.1038/nrgastro.2014.102. PMID 24957008.
  43. Wit JM, Clayton PE, Rogol AD, Savage MO, Saenger PH, Cohen P (2008). "Idiopathic short stature: definition, epidemiology, and diagnostic evaluation". Growth Horm IGF Res. 18 (2): 89–110. doi:10.1016/j.ghir.2007.11.004. PMID 18182313.
  44. Ouni M, Castell AL, Rothenbuhler A, Linglart A, Bougnères P (2015). "Higher methylation of the IGF1 P2 promoter is associated with idiopathic short stature". Clin Endocrinol (Oxf). doi:10.1111/cen.12867. PMID 26218795.
  45. Ghosh KN, Bhattacharya A (1992). "Gonotrophic nature of Phlebotomus argentipes (Diptera: Psychodidae) in the laboratory". Rev Inst Med Trop Sao Paulo. 34 (2): 181–2. PMID 1340034.